PharmaSynth AS

Aktsiaselts · 11044101 · Registrisse kantud

Activity

PharmaSynth AS is a micro enterprise in manufacturing, with declared activity “Põhifarmaatsiatoodete tootmine” (EMTAK 21101). Annual revenue stands at 586.7 k € with 8 employees, ranks #2043 of 12,089 in manufacturing.

Manufacturing

Overview (2024)

Revenue
586.7 k €
▼ 7.7%YoY
▲ 17×above industry median
Profit
152.1 k €
▲ 4.6%YoY
Profit margin
25.9%
Employees
8
▲ 14.3%YoY
▲ 8.0×above industry median
Revenue per employee
73.3 k €
Cost per employee
46.7 k €
Equity
1.05 M €

Growth

Revenue
586.7 k €
▼ 7.7%
1y
▲ 4.7%
3y CAGR
—
5y CAGR
Profit
152.1 k €
▲ 4.6%
1y
▼ 15.0%
3y CAGR
—
5y CAGR
Employees
8
▲ 14.3%
1y
▲ 4.6%
3y CAGR
—
5y CAGR

Trends

Revenue trend
586.7 k €
Profit trend
152.1 k €
Headcount trend
8

Revenue to profit

587 k €Revenue−373 k €Labor cost−61 k €Other costs152 k €Profit

Capital structure

  • Equity93%
  • Liabilities7%

Financials

YearRevenueGrowthProfitMarginEmployeesRevenue per employeeEquity
2024 ✓586.7 k €▼ 7.7%152.1 k €26%873.3 k €1.05 M €
2023 ✓635.4 k €▲ 33.6%145.5 k €23%790.8 k €896.2 k €
2022 ✓475.6 k €▼ 6.9%121.4 k €26%767.9 k €750.8 k €
2021 ✓510.8 k €▲ 14.9%247.8 k €49%773.0 k €629.3 k €
2020 ✓444.4 k €—199.1 k €45%763.5 k €381.5 k €
2019 ✓———————

Similar companies

Same industry, comparable revenue.

Official announcements

Bankruptcy notices, liquidation notices, and other official statements about the company.

View announcements on Ametlikud Teadaanded →

Court rulings

Public court decisions where the company or its registry code is mentioned.

Search court rulings on Riigi Teataja →

General info

Beneficial owners

Individuals who ultimately own or control the company.

Board (1)